|
|
Volumn 96, Issue 24, 2004, Pages 1811-
|
|
ASCO recommends aromatase inhibitors for adjuvant therapy for breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
EXEMESTANE;
HORMONE RECEPTOR;
LETROZOLE;
TAMOXIFEN;
BLOOD CLOTTING DISORDER;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CLINICAL TRIAL;
FEMALE;
FRACTURE;
HUMAN;
MEDICAL SOCIETY;
NOTE;
ONCOLOGY;
OSTEOPOROSIS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
UNITED STATES;
UTERUS CANCER;
|
|
EID: 11444266041
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.24.1811 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|